BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15358530)

  • 1. Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer.
    Sgarra R; Rustighi A; Tessari MA; Di Bernardo J; Altamura S; Fusco A; Manfioletti G; Giancotti V
    FEBS Lett; 2004 Sep; 574(1-3):1-8. PubMed ID: 15358530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties.
    Sgarra R; Maurizio E; Zammitti S; Lo Sardo A; Giancotti V; Manfioletti G
    J Proteome Res; 2009 Jun; 8(6):2978-89. PubMed ID: 19317492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational role for the C-terminal tail of the intrinsically disordered high mobility group A (HMGA) chromatin factors.
    Maurizio E; Cravello L; Brady L; Spolaore B; Arnoldo L; Giancotti V; Manfioletti G; Sgarra R
    J Proteome Res; 2011 Jul; 10(7):3283-91. PubMed ID: 21545188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA proteins: flexibility finds a nuclear niche?
    Reeves R
    Biochem Cell Biol; 2003 Jun; 81(3):185-95. PubMed ID: 12897853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells.
    Jiang X; Wang Y
    Biochemistry; 2006 Jun; 45(23):7194-201. PubMed ID: 16752910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential HMGA expression and post-translational modifications in prostatic tumor cells.
    Diana F; Di Bernardo J; Sgarra R; Tessari MA; Rustighi A; Fusco A; Giancotti V; Manfioletti G
    Int J Oncol; 2005 Feb; 26(2):515-20. PubMed ID: 15645138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of high mobility group (HMG) chromatin proteins in DNA repair.
    Reeves R; Adair JE
    DNA Repair (Amst); 2005 Jul; 4(8):926-38. PubMed ID: 15916927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin architecture and functions: the role(s) of poly(ADP-RIBOSE) polymerase and poly(ADPribosyl)ation of nuclear proteins.
    Faraone-Mennella MR
    Biochem Cell Biol; 2005 Jun; 83(3):396-404. PubMed ID: 15959565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible covalent posttranslational modification of histone H3.
    Bode AM; Dong Z
    Sci STKE; 2005 Apr; 2005(281):re4. PubMed ID: 15855410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA Interactome: new insights from phage display technology.
    Malini E; Maurizio E; Bembich S; Sgarra R; Edomi P; Manfioletti G
    Biochemistry; 2011 May; 50(17):3462-8. PubMed ID: 21417337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction proteomics of the HMGA chromatin architectural factors.
    Sgarra R; Furlan C; Zammitti S; Lo Sardo A; Maurizio E; Di Bernardo J; Giancotti V; Manfioletti G
    Proteomics; 2008 Nov; 8(22):4721-32. PubMed ID: 18850631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone acetylation and methylation: combinatorial players for transcriptional regulation.
    An W
    Subcell Biochem; 2007; 41():351-69. PubMed ID: 17484136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin proteomics and epigenetic regulatory circuits.
    Bönisch C; Nieratschker SM; Orfanos NK; Hake SB
    Expert Rev Proteomics; 2008 Feb; 5(1):105-19. PubMed ID: 18282127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mobility group proteins and their post-translational modifications.
    Zhang Q; Wang Y
    Biochim Biophys Acta; 2008 Sep; 1784(9):1159-66. PubMed ID: 18513496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arabidopsis chromatin-associated HMGA and HMGB use different nuclear targeting signals and display highly dynamic localization within the nucleus.
    Launholt D; Merkle T; Houben A; Schulz A; Grasser KD
    Plant Cell; 2006 Nov; 18(11):2904-18. PubMed ID: 17114349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translational modifications of Desulfovibrio vulgaris Hildenborough sulfate reduction pathway proteins.
    Gaucher SP; Redding AM; Mukhopadhyay A; Keasling JD; Singh AK
    J Proteome Res; 2008 Jun; 7(6):2320-31. PubMed ID: 18416566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin modifier enzymes, the histone code and cancer.
    Santos-Rosa H; Caldas C
    Eur J Cancer; 2005 Nov; 41(16):2381-402. PubMed ID: 16226460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin modifications in the germinal vesicle (GV) of mammalian oocytes.
    De La Fuente R
    Dev Biol; 2006 Apr; 292(1):1-12. PubMed ID: 16466710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.
    Bustin M; Reeves R
    Prog Nucleic Acid Res Mol Biol; 1996; 54():35-100. PubMed ID: 8768072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.